Rein Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNTX and other ETFs, options, and stocks.About RNTX
Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers.
CEOBrian J. Windsor
CEOBrian J. Windsor
Employees11
Employees11
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded2001
Founded2001
Employees11
Employees11
RNTX Key Statistics
Market cap40.03M
Market cap40.03M
Price-Earnings ratio-0.52
Price-Earnings ratio-0.52
Dividend yield—
Dividend yield—
Average volume36.76K
Average volume36.76K
High today$1.82
High today$1.82
Low today$1.53
Low today$1.53
Open price$1.53
Open price$1.53
Volume24.75K
Volume24.75K
52 Week high$4.40
52 Week high$4.40
52 Week low$1.35
52 Week low$1.35
People also own
Based on the portfolios of people who own RNTX. This list is generated using Robinhood data, and it’s not a recommendation.